Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 13 | 2020 | 349 | 1.840 |
Why?
|
| Pericardium | 9 | 2019 | 55 | 1.740 |
Why?
|
| Calcinosis | 4 | 2013 | 146 | 0.980 |
Why?
|
| Atherosclerosis | 11 | 2020 | 788 | 0.910 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2019 | 1462 | 0.780 |
Why?
|
| Ethnic Groups | 3 | 2020 | 474 | 0.710 |
Why?
|
| Coronary Artery Disease | 4 | 2013 | 413 | 0.610 |
Why?
|
| Aging | 7 | 2020 | 938 | 0.570 |
Why?
|
| Aged | 33 | 2020 | 10538 | 0.550 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 1140 | 0.540 |
Why?
|
| Obesity | 7 | 2020 | 1152 | 0.540 |
Why?
|
| Cognition | 3 | 2020 | 551 | 0.530 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 4032 | 0.530 |
Why?
|
| Lipids | 4 | 2019 | 229 | 0.510 |
Why?
|
| Body Composition | 6 | 2019 | 388 | 0.470 |
Why?
|
| Cholesterol | 2 | 2019 | 253 | 0.450 |
Why?
|
| Female | 37 | 2020 | 20261 | 0.450 |
Why?
|
| Male | 35 | 2020 | 19641 | 0.430 |
Why?
|
| Monocytes | 4 | 2017 | 130 | 0.420 |
Why?
|
| Genome-Wide Association Study | 9 | 2020 | 549 | 0.420 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 73 | 0.420 |
Why?
|
| Middle Aged | 27 | 2020 | 12125 | 0.410 |
Why?
|
| Body Mass Index | 7 | 2010 | 908 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 835 | 0.410 |
Why?
|
| Coronary Vessels | 3 | 2013 | 164 | 0.410 |
Why?
|
| European Continental Ancestry Group | 6 | 2020 | 1163 | 0.400 |
Why?
|
| DNA Methylation | 5 | 2019 | 144 | 0.390 |
Why?
|
| Coronary Circulation | 2 | 2011 | 40 | 0.380 |
Why?
|
| Risk Factors | 16 | 2019 | 3974 | 0.370 |
Why?
|
| Humans | 40 | 2020 | 32798 | 0.360 |
Why?
|
| Cognition Disorders | 1 | 2014 | 370 | 0.350 |
Why?
|
| Myocardium | 1 | 2011 | 191 | 0.330 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 881 | 0.330 |
Why?
|
| Cohort Studies | 9 | 2019 | 1844 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 1307 | 0.320 |
Why?
|
| Asian Continental Ancestry Group | 3 | 2020 | 108 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2019 | 947 | 0.290 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 28 | 0.290 |
Why?
|
| Coronary Disease | 1 | 2009 | 214 | 0.280 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 66 | 0.270 |
Why?
|
| Stroke | 2 | 2017 | 609 | 0.260 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 43 | 0.260 |
Why?
|
| Haplotypes | 1 | 2006 | 220 | 0.250 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 1572 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 1066 | 0.250 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 183 | 0.240 |
Why?
|
| African Continental Ancestry Group | 4 | 2019 | 363 | 0.220 |
Why?
|
| Asian Americans | 2 | 2019 | 95 | 0.210 |
Why?
|
| Adult | 10 | 2019 | 9560 | 0.210 |
Why?
|
| Hypertension | 3 | 2017 | 976 | 0.200 |
Why?
|
| Transcription Factors | 3 | 2019 | 176 | 0.190 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 483 | 0.190 |
Why?
|
| Depression | 2 | 2018 | 448 | 0.190 |
Why?
|
| Genetic Loci | 2 | 2019 | 146 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 22 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2020 | 51 | 0.160 |
Why?
|
| Incidence | 7 | 2020 | 1238 | 0.160 |
Why?
|
| Metformin | 1 | 2020 | 23 | 0.160 |
Why?
|
| Coronary Angiography | 2 | 2013 | 162 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2012 | 76 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 35 | 0.150 |
Why?
|
| Fats | 1 | 2019 | 2 | 0.150 |
Why?
|
| Inflammation | 3 | 2020 | 536 | 0.150 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 180 | 0.150 |
Why?
|
| Heart Failure | 2 | 2020 | 695 | 0.140 |
Why?
|
| Brain | 2 | 2014 | 946 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 334 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 142 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 256 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2017 | 136 | 0.130 |
Why?
|
| Liver | 1 | 2019 | 492 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 475 | 0.120 |
Why?
|
| Exercise | 2 | 2019 | 679 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2015 | 35 | 0.120 |
Why?
|
| Waist Circumference | 3 | 2010 | 92 | 0.120 |
Why?
|
| Sex Factors | 2 | 2017 | 675 | 0.110 |
Why?
|
| Smoking | 1 | 2019 | 531 | 0.110 |
Why?
|
| Linear Models | 4 | 2010 | 445 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 55 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 779 | 0.110 |
Why?
|
| Weight Loss | 2 | 2015 | 457 | 0.110 |
Why?
|
| Aortic Diseases | 2 | 2013 | 62 | 0.110 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 85 | 0.110 |
Why?
|
| Phenotype | 3 | 2020 | 638 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 63 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2017 | 862 | 0.100 |
Why?
|
| Aortography | 1 | 2013 | 16 | 0.100 |
Why?
|
| Genotype | 3 | 2019 | 731 | 0.100 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 73 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 363 | 0.100 |
Why?
|
| Pharyngeal Muscles | 1 | 2012 | 5 | 0.100 |
Why?
|
| Deglutition | 1 | 2012 | 30 | 0.100 |
Why?
|
| African Americans | 2 | 2010 | 1424 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2013 | 2327 | 0.090 |
Why?
|
| Perfusion | 1 | 2011 | 74 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2011 | 162 | 0.080 |
Why?
|
| Health Status | 1 | 2013 | 402 | 0.080 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 107 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2010 | 47 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 1544 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 682 | 0.080 |
Why?
|
| Tunica Media | 1 | 2010 | 28 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 101 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2013 | 1460 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2010 | 57 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2010 | 39 | 0.080 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 32 | 0.080 |
Why?
|
| Heart Atria | 1 | 2010 | 78 | 0.080 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 237 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 50 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 764 | 0.080 |
Why?
|
| Postmenopause | 1 | 2011 | 427 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 38 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 175 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 35 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 171 | 0.070 |
Why?
|
| Hispanic Americans | 2 | 2019 | 930 | 0.070 |
Why?
|
| Triglycerides | 2 | 2019 | 228 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 134 | 0.070 |
Why?
|
| Young Adult | 3 | 2019 | 2730 | 0.070 |
Why?
|
| Health Surveys | 1 | 2008 | 200 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 168 | 0.070 |
Why?
|
| Mobility Limitation | 1 | 2009 | 220 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 263 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2009 | 876 | 0.060 |
Why?
|
| Body Size | 1 | 2007 | 34 | 0.060 |
Why?
|
| Adolescent | 3 | 2019 | 3638 | 0.060 |
Why?
|
| Life Style | 2 | 2019 | 407 | 0.060 |
Why?
|
| Continental Population Groups | 2 | 2019 | 236 | 0.060 |
Why?
|
| Kidney | 1 | 2010 | 520 | 0.060 |
Why?
|
| Skin | 1 | 2008 | 214 | 0.060 |
Why?
|
| Alleles | 1 | 2006 | 253 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 208 | 0.060 |
Why?
|
| Adiposity | 3 | 2011 | 198 | 0.060 |
Why?
|
| Organ Size | 2 | 2019 | 219 | 0.060 |
Why?
|
| United States | 4 | 2019 | 4108 | 0.050 |
Why?
|
| CpG Islands | 2 | 2015 | 45 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 316 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 524 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2003 | 240 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 213 | 0.050 |
Why?
|
| Age Factors | 3 | 2011 | 1197 | 0.040 |
Why?
|
| Genetics | 1 | 2020 | 3 | 0.040 |
Why?
|
| Interleukin-7 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2020 | 33 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 17 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 44 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 58 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 6 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 352 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 19 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 16 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 47 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 185 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2019 | 63 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 105 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 117 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2019 | 72 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 9 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 9 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 370 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 488 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2019 | 251 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 53 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 23 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 102 | 0.030 |
Why?
|
| North Carolina | 2 | 2011 | 1546 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2008 | 136 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 887 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1012 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1002 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 26 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 38 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 343 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 55 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 2511 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 129 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 132 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 12 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 24 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 21 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 29 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 92 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 15 | 0.020 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2012 | 4 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 168 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2013 | 60 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2013 | 39 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 292 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 240 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 52 | 0.020 |
Why?
|
| Head | 1 | 2012 | 55 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 146 | 0.020 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 14 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 386 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 74 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 150 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 2284 | 0.020 |
Why?
|
| Aorta | 1 | 2010 | 127 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 148 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 7569 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 201 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 104 | 0.020 |
Why?
|
| Meat | 1 | 2008 | 16 | 0.020 |
Why?
|
| Contrast Media | 1 | 2008 | 138 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2183 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 54 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 381 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 576 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 573 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 767 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3438 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2006 | 32 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3701 | 0.010 |
Why?
|